Search
Search Results
##search.searchResults.foundPlural##
-
IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES
1002PDF: 630HTML: 234 -
-
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1566PDF: 497MP4: 425Html: 198 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3307PDF: 1559HTML: 454 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3970PDF: 1127HTML: 462 -
-
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1300PDF: 893HTML: 322 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1335PDF: 878HTML: 1036Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 184 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2760PDF: 1093HTML: 2583 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1680PDF: 658HTML: 2437 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3408PDF: 1300HTML: 2231Fi.1 Gritti.Rambaldi: 210 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1851PDF: 925HTML: 970Referring article: 754 -
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1319PDF: 608HTML: 3105 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1426PDF: 830HTML: 3124 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
2003PDF: 925HTML: 1770Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 170 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2893PDF: 1454HTML: 3058Cover Letter: 213 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2639PDF: 948HTML: 558 -
PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas
1592PDF: 604HTML: 222 -
-
ACQUIRED REFRACTORY IRON DEFICIENCY
3439PDF: 1153HTML: 1095 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2844PDF: 1140HTML: 11227 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2713PDF: 982HTML: 596 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1174PDF: 488HTML: 329 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1474PDF: 955HTML: 412 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2607PDF: 815HTML: 5231 -
-
High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children
984PDF: 614HTML: 291 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4459PDF: 1652HTML: 4067Tables and Images: 234 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1578PDF: 772HTML: 2153Untitled: 228Untitled: 200Untitled: 197Untitled: 208Untitled: 202 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1380PDF: 769HTML: 524 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2013PDF: 824HTML: 226 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1565PDF: 919HTML: 1968Figure: 175Tables: 192ALL revision 1: 248response to reviewer: 186 -
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
2460HTML: 9400DOCX: 1016Tables Dengue: 213







